文献速递生殖医学

择期生育力保存中的卵母细胞玻璃化冷冻:SWOT分析

Oocyte vitrification for elective fertility preservation: a SWOT analysis.
PubMed 文献 · Reprod Biomed Online · 2022-02-05

卵母细胞玻璃化冷冻(卵子冷冻)正被越来越多女性用于预防预期生育力下降,在允许该操作的国家已成为生育诊所治疗组合的组成部分。择期卵母细胞玻璃化冷冻(EEF)在成本效益、医学和伦理方面仍存争议;玻璃化冷冻技术虽革新了不孕症治疗,但考虑EEF时需明确其利弊。

要点

  • 择期卵母细胞玻璃化冷冻在允许的国家已成为生育诊所治疗组合的组成部分。
  • 推迟生育的普遍趋势与实验室技术进步促使女性考虑卵子冷冻以增加生殖自主权。
  • EEF在成本效益、医学和伦理方面仍存争议,考虑时需明确其利弊。

核心结论

  • 玻璃化冷冻技术革新了不孕症治疗,但考虑择期卵母细胞玻璃化冷冻时需明确其利弊。

研究设计与样本

  • 本文为SWOT分析,未报告系统检索范围与样本量。

主要发现

  • 择期卵母细胞玻璃化冷冻在允许该操作的国家已成为生育诊所治疗组合的组成部分。
  • 推迟生育的普遍趋势和实验室技术进步促使女性考虑卵母细胞玻璃化冷冻,以增加生殖自主权。
  • EEF在成本效益、医学和伦理方面仍存争议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oocyte vitrification, also known as egg freezing, is increasingly being used by women as a precautionary measure against the anticipated decline in fertility. In countries where this procedure is allowed, elective oocyte vitrification has become an integral part of the treatment portfolio of fertility clinics. The widespread tendency towards the postponement of motherhood and the advances in laboratory technologies are encouraging women to consider oocyte vitrification and, by doing so, increase their reproductive autonomy. However, elective oocyte vitrification, or elective egg freezing (EEF), still elicits controversy, not only when EEF is appraised from a cost-efficiency point of view, but also in terms of medical and ethical concerns. In general, although the laboratory tool of vitrification has revolutionized the treatment of infertility, the pros and cons need to be clarified when considering EEF.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Gil-Arribas E, Blockeel C, Pennings G, et al. Oocyte vitrification for elective fertility preservation: a SWOT analysis. Reprod Biomed Online. 2022. PMID: 35304091. doi:10.1016/j.rbmo.2022.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。